Table 3.
Adverse events during the first year of transplantation, n (%)
| Days of hospitalization, mean ± SD | 49 ± 45 |
| Range, d | 8–357 |
| BK virus | 16 (10.3) |
| CMV | 67 (42.9) |
| Infection | 134 (83.2) |
| Severe infection | 96 (60) |
| Bacterial infection | 112 (69.6) |
| Recurrent urinary tract infections | 29 (18.7) |
| Pneumonitis | 31 (19.6) |
| Viral infection | 21 (13.3) |
| Fungal infection | 16 (10.1) |
| Parasitic infection | 6 (3.9) |
| Cardiovascular event | 73 (45.1) |
| ADHF | 23 (13.5) |
| Recurrent ADHF | 10 (5.8) |
| Deep vein thrombosis/Pulmonary embolism | 22 (12.9) |
| Arrhythmia | 19 (11.1) |
| Myocardial ischemia | 10 (5.8) |
| Cerebrovascular event | 3 (1.8) |
| Urologic complication | 94 (56.9) |
| Lymphocele | 19 (11.1) |
| Hematoma | 19 (11.1) |
| Acute urinary retention | 18 (10.5) |
| Ureteral stenosis | 18 (10.5) |
| Transplant renal artery stenosis | 9 (5.3) |
| Skin tumor | 11 (7.1) |
| Solid tumor | 5 (3.2) |
| Hemopathy/Lymphoma | 6 (3.8) |
| TCMR | 27 (17.1) |
| Time to TCMR, d (mean ± SD) | 124 ± 104 |
| ABMR | 8 (5.2) |
| Time to ABMR, d (mean ± SD) | 171 ± 128 |
| Death | 17 (9.9) |
| Cause of death | |
| Infection | 10 (58.8) |
| Cardiovascular disease | 5 (29.4) |
| Graft loss | 40 (23.4) |
| Death-censored graft loss | 29 (16.9) |
| Cause of graft loss | |
| Death | 11 (28.2) |
| Rejection | 10 (25.6) |
| Vascular | 7 (17.9) |
ABMR, antibody-mediated rejection; ADHF, acute decompensated heart failure; CMV, cytomegalovirus; TCMR, T-cell mediated rejection.